Drugmaker Mylan N.V. on Wednesday reported a 31 percent increase in profit for the first quarter from last year as lower expenses and a tax benefit helped offset a slight decline in revenues. However, both revenue and adjusted earnings missed analysts' expectations. North America segment net sales fell 19 percent. Looking ahead, the company reaffirmed its financial outlook for fiscal 2018.
from RTT - Earnings https://ift.tt/2I1mLm3
via IFTTT
No comments:
Post a Comment